Early Inflammatory Bowel Disease Progression
Observational · No treatment assigned · 1 site · Pontificia Universidad Catolica de Chile
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases, Crohn Disease (CD) and Ulcerative Colitis (UC). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 100
- Any sex
Some of the main requirements, copied from the record:
- Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 140 participants are expected to take part.
- Start date: 2023-07-07.
- Main results expected around 2027-04 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Chile.
Main thing being measured
- Compare gut microbiome composition and function from different sample types among participants with gastrointestinal symptoms with and without confirmed IBD by colonoscopy and biopsy (36 months)
In the researchers’ words
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases; Crohn Disease (CD); Ulcerative Colitis (UC) |
| Lead sponsor | Pontificia Universidad Catolica de Chile |
| Collaborators | Fondo Nacional de Desarrollo Científico y Tecnológico, Chile |
| Enrollment | 140 (estimated) |
| Start date | 2023-07-07 |
| Primary completion (est.) | 2027-04 |
| First posted | 2025-01-01 |
| Last updated | 2025-01-01 |
| Official title | Composition and Metabolic Activity of Gut Microbiota to Predict Early Inflammatory Bowel Disease Progression |
| ClinicalTrials.gov ID | NCT06756100 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency Exclusion Criteria: * Confirmed infectious disease of the gastrointestinal tract
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Pontificia Universidad Catolica of Chile | Santiago | Chile | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.